HUA MEDICINE
(HKEX: 2552)
Hua Medicine Ltd. provides drug discovery and development services. It offers drugs for diabetes and Central Nervous System disorders. Its products include Dorzagliatin HMS552, Dorzagliatin+Metformin, Dorzagliatin+DPPIV, Dorzagliatin+SGLT-2, Dorzagliatin+Insulin, Dorzagliatin+GLP-1 and mGLUR5 NAM. The company was founded by Chen Li on November 10, 2009 and is headquartered in Shanghai, China.
3.260 -
-0.020
(-0.61%)
Range
3.190 - 3.300
(3.45%)
Open
3.250
Previous Close
3.280
Bid Price
3.260
Bid Volume
('000)
6.5
Ask Price
3.280
Ask Volume
('000)
30
Volume
('000)
1,611.5
Value
5,232,840
Remark
-
Delayed prices. Updated at 05 Dec 2025 16:09.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
